459 related articles for article (PubMed ID: 26774959)
1. Physical Activity and Survival After Prostate Cancer.
Friedenreich CM; Wang Q; Neilson HK; Kopciuk KA; McGregor SE; Courneya KS
Eur Urol; 2016 Oct; 70(4):576-585. PubMed ID: 26774959
[TBL] [Abstract][Full Text] [Related]
2. Recreational Physical Activity in Relation to Prostate Cancer-specific Mortality Among Men with Nonmetastatic Prostate Cancer.
Wang Y; Jacobs EJ; Gapstur SM; Maliniak ML; Gansler T; McCullough ML; Stevens VL; Patel AV
Eur Urol; 2017 Dec; 72(6):931-939. PubMed ID: 28711382
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.
Pernar CH; Ebot EM; Pettersson A; Graff RE; Giunchi F; Ahearn TU; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Stopsack KH; Gazeeva E; Lis RT; Parmigiani G; Rimm EB; Finn SP; Giovannucci EL; Fiorentino M; Mucci LA
Eur Urol; 2019 Jul; 76(1):33-40. PubMed ID: 30301696
[TBL] [Abstract][Full Text] [Related]
4. Associations of Postdiagnosis Physical Activity and Change from Prediagnosis Physical Activity with Quality of Life in Prostate Cancer Survivors.
Farris MS; Kopciuk KA; Courneya KS; McGregor SE; Wang Q; Friedenreich CM
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):179-187. PubMed ID: 27677728
[TBL] [Abstract][Full Text] [Related]
5. Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial.
Godtman RA; Holmberg E; Khatami A; Pihl CG; Stranne J; Hugosson J
Eur Urol; 2016 Nov; 70(5):760-766. PubMed ID: 27090975
[TBL] [Abstract][Full Text] [Related]
6. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
[TBL] [Abstract][Full Text] [Related]
7. Prospective Cohort Study of Pre- and Postdiagnosis Physical Activity and Endometrial Cancer Survival.
Friedenreich CM; Cook LS; Wang Q; Kokts-Porietis RL; McNeil J; Ryder-Burbidge C; Courneya KS
J Clin Oncol; 2020 Dec; 38(34):4107-4117. PubMed ID: 33026939
[TBL] [Abstract][Full Text] [Related]
8. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study.
Kenfield SA; Stampfer MJ; Giovannucci E; Chan JM
J Clin Oncol; 2011 Feb; 29(6):726-32. PubMed ID: 21205749
[TBL] [Abstract][Full Text] [Related]
9. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies.
Lahart IM; Metsios GS; Nevill AM; Carmichael AR
Acta Oncol; 2015 May; 54(5):635-54. PubMed ID: 25752971
[TBL] [Abstract][Full Text] [Related]
10. Physical activity and survival after colorectal cancer diagnosis.
Meyerhardt JA; Giovannucci EL; Holmes MD; Chan AT; Chan JA; Colditz GA; Fuchs CS
J Clin Oncol; 2006 Aug; 24(22):3527-34. PubMed ID: 16822844
[TBL] [Abstract][Full Text] [Related]
11. Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men.
Patel AV; Rodriguez C; Jacobs EJ; Solomon L; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):275-9. PubMed ID: 15668508
[TBL] [Abstract][Full Text] [Related]
12. Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study).
Nilsen TI; Romundstad PR; Vatten LJ
Int J Cancer; 2006 Dec; 119(12):2943-7. PubMed ID: 17019717
[TBL] [Abstract][Full Text] [Related]
13. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival.
Campbell PT; Patel AV; Newton CC; Jacobs EJ; Gapstur SM
J Clin Oncol; 2013 Mar; 31(7):876-85. PubMed ID: 23341510
[TBL] [Abstract][Full Text] [Related]
14. Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.
Moschini M; Sharma V; Zattoni F; Quevedo JF; Davis BJ; Kwon E; Karnes RJ
Eur Urol; 2016 Jan; 69(1):135-42. PubMed ID: 25865061
[TBL] [Abstract][Full Text] [Related]
15. Natural history of early, localized prostate cancer: a final report from three decades of follow-up.
Popiolek M; Rider JR; Andrén O; Andersson SO; Holmberg L; Adami HO; Johansson JE
Eur Urol; 2013 Mar; 63(3):428-35. PubMed ID: 23084329
[TBL] [Abstract][Full Text] [Related]
16. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
[TBL] [Abstract][Full Text] [Related]
17. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
18. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
[TBL] [Abstract][Full Text] [Related]
19. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
Voog JC; Paulus R; Shipley WU; Smith MR; McGowan DG; Jones CU; Bahary JP; Zeitzer KL; Souhami L; Leibenhaut MH; Rotman M; Husain SM; Gore E; Raben A; Chafe S; Sandler HM; Efstathiou JA
Eur Urol; 2016 Feb; 69(2):204-10. PubMed ID: 26362090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
